Mastering PSUR and PBRER Drafting for Global Markets

Effective PSUR and PBRER Drafting is essential for maintaining a product’s marketing authorization. These aggregate reports provide a high-level medical analysis of the drug’s safety and efficacy.

Challenges in Aggregate Reporting

The biggest challenge in PSUR and PBRER Drafting is data cut-off management. Ensuring that data from all global sources (US, EU, APAC) is cleaned and analyzed within the tight submission windows requires world-class Quality management.

As a Strategic Partner, we assist MAHs in streamlining their PSUR and PBRER Drafting to ensure 100% submission compliance.